Alnylam Pharmaceuticals Inc.

(ALNY)

By |

Profile

Alnylam Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in developing novel therapeutics based on RNA interference, or RNAi. RNAi is a naturally occurring biological pathway within cells for regulating the expression of specific genes.

Contact Information

Website: www.alnylam.com
Main Phone: +1 617 551-8200
Address: 300 Third Street
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02142

Issuer Information

Exchange: NGS
Employees: 369
NAICS: Pharmaceutical P
$ 41.24 $ 0.00 (0.00%)
Last Price 41.24 Change $ 0.00 Change % 0.00 Tick N/A
Bid 40.56 Bid Size 100.00 Ask 45.76 Ask Size 700.00
Open N/A High N/A Low N/A Prev Close 41.24
Last Trade Volume 0 52 Wk Hi 105.84 52 Wk Low 31.38
Market Cap 3.5 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 85,813,869.00 EPS (TTM) -4.54 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 7 68
Number of Buys 2 22
Number of Sells 5 46
Net Activity 0 29754
Last 10 Buys Shares
Michael W. Bonney 1,000
David-Alexandre Gros 1,000
David-Alexandre Gros 1,000
Michael W. Bonney 1,000
Steven M. Paul 1,000
John M. Maraganore 1,000
Phillip A. Sharp 1,000
John M. Maraganore 1,000
Barry E. Greene 1,000
Paul R. Schimmel 1,000
Last 10 Sell Shares
John M. Maraganore 1,000
John M. Maraganore 1,000
John M. Maraganore 1,000
John M. Maraganore 1,000
John M. Maraganore 1,000
John M. Maraganore 1,000
John M. Maraganore 1,000
John M. Maraganore 1,000
John M. Maraganore 1,000
John M. Maraganore 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 180 180 180 180
Low Target Price Estimate 85 83 80 85
Mean Target Price Estimate 116.75 113 112.11 116.75
Standard Deviation 33.22 33.05 33.94 33.22
Date of Most Recent Estimate 08/16/16 08/08/16 08/02/16 08/23/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 7 8 8 8
Moderate Buy 1 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.28 1.22 1.22 1.22